(Q36495565)

14 August 2017

1 reference

title

Neuroendocrine effects of psychotropic drugs (English)

1 reference

14 August 2017

2 Neuroendocrine effects of psychotropic drugs (English)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

26 October 2022

author name string

S. Checkley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1674856

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1674856

26 October 2022

publication date

1 March 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:S0950351X05800941?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

https://api.elsevier.com/content/article/PII:S0950351X05800941?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

Bailliere's clinical endocrinology and metabolism

26 October 2022

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

15-33

1 reference

Who responds to prophylactic lithium?

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Adrenergic mechanisms in the control of corticotrophin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium and symptomatic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Water Disturbances in Patients Treated with Oral Lithium Carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

A study of sulphatoxymelatonin excretion and gonadotrophin status during weight gain in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

The effects of phenothiazines on endocrine function: II. Effects in men and post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Development of 'primary' hyperparathyroidism during lithium therapy: longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effects of Desipramine Treatment upon Central Adrenoceptor Function in Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Atenolol reduces plasma melatonin concentration in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of amitriptyline on endocrine responses to intravenous L-trytophan

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

A randomised controlled trial of prophylactic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Melatonin and cortisol increase after fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Serum Thyrotropin and Thyroxine Concentrations in Patients Receiving Lithium Carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Up- and down-regulation of central postsynaptic ?2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

On the mechanism of lithium-induced diabetes insipidus in man and the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Acute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Long-term lithium carbonate therapy causes hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium in the treatment of mania: comparisons with neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium effects on neuroendocrine function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Plasma arginine-vasopressin, renal-concentrating ability and lithium excretion in a group of patients on long-term lithium treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Endocrine and behavioural responses to methylphenidate in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--I. Growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of lithium on hypothalamic-pituitary dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Dopaminergic factors in human prolactin regulation: A pituitary model for the study of a neuroendocrine system in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Serum prolactin and clinical state during neuroleptic treatment and withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium therapy and thyroid function: a long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Trial of Maintenance Therapy in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Prolactin, amitriptyline, and recovery from depression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium increases 5-HT-mediated prolactin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of lithium on hypothalamic-pituitary-thyroid function in patients with affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium and the antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Inhibition of prolactin secretion by nomifensine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of clozapine on human serum prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Stimulation of growth hormone by GHRH as compared to DMI in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Embryopathic effects of lead in the hamster: a morphologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium carbonate and plasma cortisol response in the ffective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Prolactin response to single and multiple doses of haloperidol in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Relations between psychotic symptoms and serum prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Selective neuroendocrine effects of low-dose haloperidol in normal adult men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Paradoxical cortisol responses to dextroamphetamine in endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Desmethylimipramine treatment increases melatonin production in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Occurrence of goitre during lithium treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium-induced hyperparathyroidism: an alteration of the "set-point"

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Long-term Benzodiazepine Administration Blunts Growth Hormone Response to Diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Effects of dopamine blockade on gonadotropins and testosterone in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Cortisol changes in long-term lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Lithium therapy and thyroid function tests. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

The Effect of Short Term Lithium Administration on Suppressibility of Parathyroid Hormone Secretion by Calciumin Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Inhibition by lithium of dopamine receptors in rat prolactin release

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

The effect of desipramine upon melatonin and cortisol secretion in depressed and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Impairment of cyclic AMP response to bovine parathyroid hormone in patients on chronic lithium therapy with diminished renal urine-concentrating ability

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Growth hormone (GH) release following thyrotropin-releasing hormone (TRH) injection in manic patients receiving lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980094-1

7 January 2021

Low serum prolactin and early relapse following neuroleptic withdrawal

14

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

Endocrine effects of lithium: II. 'Primary' hyperparathyroidism

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

parathyroid hormone secretion

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

Pituitary-Testicular Axis in Patients on Lithium Therapy

26 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

thyroid hormone metabolic process

26 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

The effect of lithium on luteinizing hormone and testosterone in man

26 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin

26 October 2022

123

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

Renal function during lithium treatment

26 October 2022

126

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(05)80094-1

26 October 2022

Identifiers

1 reference

14 August 2017

1 reference